Novel Strategies in the Treatment of Multiple Myeloma: From Proteasome Inhibitors to Immunotherapy

Journal of Cell Science & Therapy
doi 10.4172/2157-7013.1000101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Novel Strategies to Target the Ubiquitin Proteasome System in Multiple Myeloma

Oncotarget
Oncology
2015English

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2014English

MAFb Protein Confers Intrinsic Resistance to Proteasome Inhibitors in Multiple Myeloma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Proteasome Inhibitors Block Ikaros Degradation by Lenalidomide in Multiple Myeloma

Haematologica
Hematology
2015English

Current Developments in Immunotherapy in the Treatment of Multiple Myeloma

Cancer
Cancer ResearchOncology
2018English

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Editorial: Immunotherapy in Multiple Myeloma

Frontiers in Immunology
AllergyImmunology
2019English

Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs

International Journal of Molecular Medicine
MedicineGenetics
2011English

Resistance to Proteasome Inhibitors and Other Targeted Therapies in Myeloma

British Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy